The mechanistic link between high-fat Western diets and colorectal cancer may pivot on a specific bacterial transformation that converts protective bile compounds into tumor-promoting molecules. This finding could reshape prevention strategies for the third most common cancer worldwide, affecting over 1.9 million people annually. Researchers demonstrated that gut bacteria possessing 7α-dehydroxylating enzymes transform primary bile acids into secondary metabolites, particularly deoxycholic acid, which directly accelerates colon tumor development. Using porcine models fed Western diets, they observed increased tumor burden accompanied by elevated deoxycholic acid levels and heightened epithelial cell proliferation—effects that disappeared when bile acid-scavenging drugs blocked the process. The team then isolated Clostridium scindens and related species from human colorectal cancer patients, confirming these bacteria carry the specific genetic machinery (bai operons) responsible for bile acid conversion. When introduced into gnotobiotic mice, these bacterial strains consistently increased tumor formation across multiple cancer models. Conversely, genetically modified bacteria lacking the dehydroxylating capability produced significantly fewer tumors. This research provides the first causal evidence for a long-suspected dietary-microbial-cancer pathway, moving beyond observational studies to demonstrate direct causation. The implications extend beyond basic science—bile acid sequestrants already exist as FDA-approved medications for cholesterol management, suggesting a potential repurposing opportunity for cancer prevention. However, the complexity of gut microbiome interactions means targeting specific bacterial populations will require sophisticated approaches to avoid disrupting beneficial microbial functions. The work validates precision microbiome medicine as a legitimate cancer prevention strategy.